Endpoint Clinical builds interactive response technology (IRT/RTSM) for clinical trials, providing randomization, drug supply, and inventory management through its PULSE platform for biopharma sponsors and CROs. Its business centers on enterprise software and related services that support study setup, dosing, and clinical supply operations across global trials. Founded in 2009 and headquartered in Raleigh, North Carolina, it is privately held under Arsenal Capital Partners with offices in the United States, Europe, and Asia.